The present paper introduces results of an analysis conducted on data collected from Khartoum state for the year 2009. It aims to apply statistical models for the HIV/AIDS data in Khartoum state centers of testing blood and counseling. AIDS is recognized as an emerging disease only in the early...

The majority of injecting drug users have hepatitis C yet they are not routinely treated for it in New Zealand. This paper investigates the cost and effectiveness of treating hepatitis C virus (HCV) for injecting drug users whose drug dependence has been stabilised. Two treatments options were...

This report presents a computer model for evaluating the cost-effectiveness (CE) of Hormone Replacement Therapy (HRT). The model is an extension of a previous model and includes also the risk of spine and wrist fracture. New Swedish data on risk of coronary heart disease and related mortality...

This article examines issues potentially raised under the Americans with Disabilities Act (ADA) by states' decisions whether and how to include disabled Medicaid recipients in the massive shift towards Medicaid managed care. Part II briefly examines the special issues that disabled Medicaid...

In the early years of the Twenty-First Century, it was widely speculated that massive, multi-purpose hospitals were becoming the 'dinosaurs' of health care, to be largely replaced by community-based clinics providing specialty services on an outpatient basis. Hospitals, however, have roared back...

In the current risk climate, the loss of confidential patient data to unauthorized third parties presents a daunting challenge for healthcare professionals. In this context, the introduction of large networks of computerized health information has caused the number of individuals with access to...

Public health emergencies from natural disasters, infection, and man-made threats can present ethically or legally challenging questions about who will receive scarce resources. Federal and state governments have offered little guidance on how to prioritize distribution of limited resources....

As resistance to antibiotics continues to grow, there is a well-recognized misalignment between the clinical need for new antibiotics and the incentives for their development. The returns from investment in antibiotics research and development (R&D) are perceived as too small. Partly as a...

Antibiotics are powerful drugs that prevent many deaths each year. Modern medicine relies on them as a safety net. Many invasive medical procedures would be much more dangerous without effective antibiotics. Global trade, travel and security would be threatened by a resurgence of untreatable...

Hospital prices are almost completely irrational. They bear no relationship to the cost of providing the services, they are opaque, and the prices vary wildly among hospitals and payers. The craziness of hospital pricing was laid bare when the federal government released data on hospital charges...